Cargando…

One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review

BACKGROUND/INTRODUCTION: Early reports of stereotactic body radiation therapy (SBRT) for pancreatic ductal adenocarcinoma (PDAC) used single fraction, but eventually shifted to multifraction regimens. We conducted a single institution review of our patients treated with single- or multifraction SBRT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutera, Philip Anthony, Bernard, Mark E., Gill, Beant S., Harper, Kamran K., Quan, Kimmen, Bahary, Nathan, Burton, Steven A., Zeh, Herbert, Heron, Dwight E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694485/ https://www.ncbi.nlm.nih.gov/pubmed/29184848 http://dx.doi.org/10.3389/fonc.2017.00272

Ejemplares similares

Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation
por: Sutera, Philip, et al.
Publicado: (2018)

Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins
por: Bernard, Mark E., et al.
Publicado: (2018)

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
por: Rajagopalan, Malolan S, et al.
Publicado: (2013)

Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients
por: Kim, Carolyn H, et al.
Publicado: (2013)

Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins
por: Patel, Ankur K., et al.
Publicado: (2020)

Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma
por: Sutera, Philip A., et al.
Publicado: (2018)

Salvage Stereotactic Body Radiotherapy for Locally Recurrent Non-Small Cell Lung Cancer after Sublobar Resection and I(125) Vicryl Mesh Brachytherapy
por: Gill, Beant S., et al.
Publicado: (2015)

An Unexpected Etiology of Pancreatic Panniculitis: A Case Report
por: Evans, Anna C., et al.
Publicado: (2017)

Tumor Bed Radiosurgery Following Resection and Prior Stereotactic Radiosurgery for Locally Persistent Brain Metastasis
por: Holt, Douglas Emerson, et al.
Publicado: (2015)

Stereotactic Ablative Radiosurgery for Locally Advanced or Recurrent Skull Base Malignancies with Prior External Beam Radiation Therapy
por: Xu, Karen M., et al.
Publicado: (2015)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases
por: Leeman, Jonathan E, et al.
Publicado: (2012)

Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery
por: Quan, Kimmen, et al.
Publicado: (2015)

Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer
por: Thakur, Prakash C., et al.
Publicado: (2018)

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
por: Fei, Naomi, et al.
Publicado: (2021)

Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer
por: AlMasri, Samer, et al.
Publicado: (2022)

Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer
por: Bernard, Mark E., et al.
Publicado: (2017)

Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience
por: Glicksman, Rachel M, et al.
Publicado: (2020)

Pancreatic Cancer Presenting as a Pancreatic Duct Disruption
por: Liu, Annie, et al.
Publicado: (2019)

Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age
por: Chao, David T., et al.
Publicado: (2018)

Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma
por: Webking, Samantha, et al.
Publicado: (2023)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease
por: Dohopolski, Michael J, et al.
Publicado: (2018)

Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case‐control study (PAULA‐1)
por: Arcelli, Alessandra, et al.
Publicado: (2020)

Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer
por: Ng, Sweet Ping, et al.
Publicado: (2018)

Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
por: Nguyen, Eric K., et al.
Publicado: (2021)

Encouraging long‐term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high‐risk patients with resectable pancreatic carcinoma
por: AlMasri, Samer S., et al.
Publicado: (2021)

The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products
por: Vernon, Philip J., et al.
Publicado: (2013)

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
por: Koong, Amanda J., et al.
Publicado: (2017)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Frameless Fractionated Stereotactic Radiosurgery for Vestibular Schwannomas: A Single-Institution Experience
por: Karam, Sana D., et al.
Publicado: (2013)

Stereotactic Body Radiotherapy as an Effective Treatment for Pancreatic Cancer
por: Hurmuz, Pervin, et al.
Publicado: (2023)

Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
por: Gill, Beant, et al.
Publicado: (2012)

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma
por: Herman, Joseph M, et al.
Publicado: (2015)

Exceptional Eight-year Response to Stereotactic Radiosurgery Monotherapy for Multiple Brain Metastases
por: Kalash, Ronny, et al.
Publicado: (2017)

Pancreatic head vs pancreatic body/tail cancer: Are they different?
por: Sun, Kai, et al.
Publicado: (2022)

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, JM, et al.
Publicado: (2023)

Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience
por: Cuccia, Francesco, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
por: Stauder, Michael C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8s3ood0db45jsi87k6fjnvaor9